Melflufen Study: Lengthy Time To Next Treatment, Signific...

Melflufen Study: Lengthy Time To Next Treatment, Significant Reduction In Bone Pain, Positive Feedback From FDA Regarding HORIZON Study
3 years 557 Views
Category:
Description:
Jakob Lindberg CEO Of Oncopeptides Discusses Melflufen Study: Lengthy Time To Next Treatment, Significant Reduction In Bone Pain, Positive Feedback From FDA Regarding HORIZON Study